Arbutus Biopharma Corp (ABUS) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $71.72M2014: $118.18M2015: $712.29M2016: $275.92M2017: $237.16M2018: $227.91M2019: $105.53M2020: $137.08M2021: $204.49M2022: $195.42M2023: $144.40M2024: $131.71M2025: $94.62M$94.62M
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$94.62M-28.2%
2024$131.71M-8.8%
2023$144.40M-26.1%
2022$195.42M-4.4%
2021$204.49M+49.2%
2020$137.08M+29.9%
2019$105.53M-53.7%
2018$227.91M-3.9%
2017$237.16M-14.0%
2016$275.92M-61.3%
2015$712.29M+502.7%
2014$118.18M+64.8%
2013$71.72M